The radioprotection of salivary glands by vitamin C and sodium bicarbonate in 131I treatment of patients with differentiated thyroid carcinoma

被引：0
|
作者：
Tong, Huimin [1 ]
Gao, Ying [1 ]
Zhang, Xiaomin [1 ]
Li, Xiaoqian [1 ]
Luo, Liping [1 ]
Huang, Nan [1 ]
Hu, Tingting [1 ]
An, Jie [1 ]
Wang, Jin [1 ]
Cheng, Yan [1 ]
机构：
[1] Shanxi Med Univ, First Hosp, Taiyuan, Peoples R China
来源：
JOURNAL OF NUCLEAR MEDICINE | 2021年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1696
引用
收藏
页数：6
相关论文
共 50 条
  • [31] Usefulness of second 131I treatment in biochemical persistent differentiated thyroid cancer patients
    Gambale, Carla
    Prete, Alessandro
    Contartese, Lea
    Torregrossa, Liborio
    Bianchi, Francesca
    Molinaro, Eleonora
    Materazzi, Gabriele
    Elisei, Rossella
    Matrone, Antonio
    EUROPEAN THYROID JOURNAL, 2023, 12 (06)
  • [32] Analysis of the incidence and influencing factors of hyponatremia before 131I treatment of differentiated thyroid carcinoma
    Jing-Jia Cao
    Can-Hua Yun
    Juan Xiao
    Yong Liu
    Wei Wei
    Wei Zhang
    World Journal of Clinical Cases, 2021, (36) : 11173 - 11182
  • [33] The study of influence factors on 131I treatment of differentiated thyroid carcinoma with lymph node metastases
    Ye, Zhi-Yi
    Wang, Hui
    Fu, Hong-Liang
    Li, Jia-Ning
    Zou, Ren-Jian
    Gu, Zhen-Hui
    Wu, Jing-Chuan
    CLINICAL IMAGING, 2009, 33 (03) : 221 - 225
  • [34] Analysis of the incidence and influencing factors of hyponatremia before 131I treatment of differentiated thyroid carcinoma
    Cao, Jing-Jia
    Yun, Can-Hua
    Xiao, Juan
    Liu, Yong
    Wei, Wei
    Zhang, Wei
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (36) : 11173 - 11182
  • [35] Significance of Salivary Gland Radioiodine Retention on Post-ablation 131I Scintigraphy as a Predictor of Salivary Gland Dysfunction in Patients with Differentiated Thyroid Carcinoma
    Jo K.S.
    An Y.-S.
    Lee S.J.
    Soh E.-Y.
    Lee J.
    Chung Y.-S.
    Kim D.J.
    Yoon S.-H.
    Lee D.H.
    Yoon J.-K.
    Nuclear Medicine and Molecular Imaging, 2014, 48 (3) : 203 - 211
  • [36] Absorbed dose to the salivary glands in thyroid patients undergoing treatment with I-131.
    ElShirbiny, A
    Imbriaco, M
    Yeung, H
    Furhang, EE
    Humm, JL
    Yeh, SDJ
    ODonoghue, JA
    Macapinlac, H
    Robbins, R
    Larson, SM
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 399 - 399
  • [37] Effect of first 131I treatment on salivary gland function in patients with differentiated thyroid cancer coexisted with Hashimoto's thyroiditis
    Pang Xiaoan
    Wei Zhixiao
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [38] Practical dosimetry of 131I in patients with thyroid carcinoma
    Sisson, JC
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2002, 17 (01) : 101 - 105
  • [39] Clinical features of patients with recurrent or metastatic differentiated thyroid carcinoma after 131I therapy
    蔡晓雨
    ChinaMedicalAbstracts(InternalMedicine), 2020, 37 (04) : 205 - 206
  • [40] Efficacy and Affecting Factors of 131I Thyroid Remnant Ablation After Surgical Treatment of Differentiated Thyroid Carcinoma
    Wang, Chen
    Diao, Hongcui
    Ren, Ping
    Wang, Xufu
    Wang, Yangang
    Zhao, Wenjuan
    FRONTIERS IN ONCOLOGY, 2018, 8
12345